Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07LCM
|
|||
Former ID |
DNC008243
|
|||
Drug Name |
1-(3-methoxyphenethyl)pyrrolidine
|
|||
Synonyms |
CHEMBL404911; 1-(3-methoxyphenethyl)pyrrolidine; SCHEMBL10669091; JLMYWUJQHKXCOU-UHFFFAOYSA-N; 3-(2-pyrrolidin-1-ylethyl)anisole
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H19NO
|
|||
Canonical SMILES |
COC1=CC=CC(=C1)CCN2CCCC2
|
|||
InChI |
1S/C13H19NO/c1-15-13-6-4-5-12(11-13)7-10-14-8-2-3-9-14/h4-6,11H,2-3,7-10H2,1H3
|
|||
InChIKey |
JLMYWUJQHKXCOU-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Histamine receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Monoamine Transport | |||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical series. Bioorg Med Chem Lett. 2008 Jan 1;18(1):355-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.